Phoenix [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2014-11-11 22:05 (4248 d 11:16 ago) – Posting: # 13862
Views: 16,988

Hi Angus,

❝ Can the (subject by formulation) interaction be done in Phoenix WinNonlin?


You don’t need the templates. Run conventional ABE with the default setup:

Fixed Effects: Sequence+Period+Formulation
Variance Structure > Random 1:
Random Effects: Formulation
Variance Blocking Variables: Subject
Type: Banded No-Diagonal Factor Analytic(f), Number of factors = 2
Variance Structure > Repeated:
Repeated Specification: Period
Variance Blocking Variables: Subject
Group: Formulation
Type: Variance Components


Final Variance Parameters > lambda(2,2)_11 is the estimated subject×formulation interaction, Var(Period*Formulation*Subject)_21 is σ²wR, and Var(Period*Formulation*Subject)_22 is σ²wT. It should be possible to merge the degrees of freedom, get cinv(0.05, df), and calculate the upper bound directly. Have to check. If not, all the necessary data to follow Step 4 of the guidance are avail­able.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
281 visitors (0 registered, 281 guests [including 26 identified bots]).
Forum time: 10:22 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5